Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for ulcerative colitis: A Phase 3, randomized, placebo-controlled study: Results of the LIBERTY-UC study

Sands, BE; ...; Sreckovic, S; ...; (broj, koautora 24)

Rezultati

eNauka > Results > Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for ulcerative colitis: A Phase 3, randomized, placebo-controlled study: Results of the LIBERTY-UC study

Title:	Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for ulcerative colitis: A Phase 3, randomized, placebo-controlled study: Results of the LIBERTY-UC study
Authors:	Sands, BE; ...; Sreckovic, S; ...; (broj, koautora 24)
Issue Date:	2023
Publication:	JOURNAL OF CROHNS & COLITIS
ISSN:	1873-9946 Journal of Crohn#s and Colitis Search Idenfier
Type:	Conference Paper
Collation:	vol. 17 str. 623-624
WoS-ID:	000960367601204
URI:	https://enauka.gov.rs/handle/123456789/811043
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	Mp. category will be shown later

19
WEB OF SCIENCE^TM

Pronađi DOI

Pronalaženje DOI u servisu CrossRef-u na osnovu meta-podataka u zapisu. Prikazaće se DOI (i metapodaci) čiji se podaci najviše poklapaju. OPREZ - to ne mora biti ta publikacija.

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.